[{"NetIncomeLoss_1_Q2_USD":-19333000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":186933.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":204017.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestIncomeOther_2_Q2_USD":1214000.0,"InterestIncomeOther_1_Q2_USD":776000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":5593000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":757000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-173683000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":3787000.0,"AssetsCurrent_0_Q2_USD":813076000.0,"MarketableSecuritiesRealizedGainLoss_2_Q2_USD":-46000.0,"MarketableSecuritiesRealizedGainLoss_1_Q2_USD":-1000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_2_Q2_USD":5.99,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":190000.0,"MarketRiskBenefitChangeInFairValueGainLoss_2_Q2_USD":200000.0,"MarketRiskBenefitChangeInFairValueGainLoss_1_Q2_USD":500000.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":217759082.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":357074000.0,"BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses_2_Q2_USD":624831000.0,"Assets_0_Q2_USD":814263000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6400000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-224000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":11005000.0,"MarketableSecuritiesCurrent_0_Q2_USD":357074000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-3246000.0,"AdjustmentForAmortization_2_Q2_USD":1700000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":850000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":903868000.0,"WarrantsAndRightsOutstanding_0_Q2_USD":15061000.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0_Q2_USD":312000.0,"IncreaseDecreaseInInterestAndDividendsReceivable_2_Q2_USD":-905000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":102950000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":625021000.0,"DerivativeFairValueOfDerivativeLiability_0_Q2_USD":15061000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":58108000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":5787472.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":-207000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":-500000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-40535000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-19557000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2398000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":449533000.0,"Liabilities_0_Q2_USD":25328000.0,"DepreciationAndAmortization_2_Q2_USD":71000.0,"ShareBasedCompensation_2_Q2_USD":3719000.0,"ProfessionalFees_2_Q2_USD":284000.0,"ProfessionalFees_1_Q2_USD":176000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":231673000.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_0_Q2_USD":-601000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":757000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-39735000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-19333000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2153000.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":-754000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-31560000.0,"LiabilitiesCurrent_0_Q2_USD":10090000.0,"AccountsPayableCurrent_0_Q2_USD":4497000.0,"NonoperatingIncomeExpense_2_Q2_USD":1183000.0,"NonoperatingIncomeExpense_1_Q2_USD":1101000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_2_Q2_pure":0.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_1_Q2_pure":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":449533000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4472000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":190000.0,"StockIssued1_2_Q2_USD":3787000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":11.5,"PropertyPlantAndEquipmentNet_0_Q2_USD":766000.0,"NetIncomeLoss_2_Q2_USD":-39735000.0,"CommonStockSharesOutstanding_0_Q2_shares":217759082.0,"PaymentsToAcquireMachineryAndEquipment_2_Q2_USD":118000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":419778000.0,"MarketableSecurities_0_Q2_USD":357074000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q2_USD":242864000.0,"CommonStockSharesAuthorized_0_Q2_shares":1060000000.0,"OperatingIncomeLoss_2_Q2_USD":-40918000.0,"OperatingIncomeLoss_1_Q2_USD":-20434000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0_Q2_USD":345814000.0,"PaymentsToAcquireHeldToMaturitySecurities_2_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":814263000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3719000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2153000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":14034000.0,"OperatingExpenses_2_Q2_USD":40918000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.21,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.09,"ProfitLoss_2_Q2_USD":-39735000.0,"UnrealizedGainLossOnSecurities_2_Q2_USD":-800000.0,"UnrealizedGainLossOnSecurities_1_Q2_USD":-224000.0,"StockholdersEquity_0_Q2_USD":788935000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":356317000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":177000.0,"DeferredCostsCurrent_0_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":115690000.0,"OperatingExpenses_1_Q2_USD":20434000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":29913000.0,"Ticker":"NUVB","CIK":"1811063","name":"NUVATION BIO INC.","OfficialName":"Nuvation Bio Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1238973430.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210812"}]